Supplementation of creatine and ribose prevents apoptosis in ischemic cardiomyocytes

Cellular Physiology and Biochemistry

Volumn 26, Issue 6, 2010, Pages 831-838

  Caretti, Anna ^a   Bianciardi, Paola ^a   Sala, Giusy ^a   Terruzzi, Carlo ^b   Lucchina, Franco ^b   Samaja, Michele ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Giellepi Chemicals   (Italy)

Author keywords

Akt; AMPK; Cardiomyocytes; Creatine; Ischemia; Ribose

Indexed keywords

CASPASE 3; CREATINE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXYGEN; PROTEIN KINASE B; RIBOSE; STRESS ACTIVATED PROTEIN KINASE;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL STRESS; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 78651225353     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323992     Document Type: Article

References (38)

1. Sharov V, Saks V, Kupriyanov V, Lakomkin V, Kapelko V, Steinschneider A, Javadov S: Protection of ischemic myiocardium by exogenus phosphocreatine. J Thorac Cardiovasc Surg 1987;94:749-761.
2. Constantin-Teodosiu D, Greenhaff PL, Gardiner SM, Randall MD, March JE, Bennett T: Attenuation by creatine of myocardial metabolic stress in brattleboro rats caused by chronic inhibition of nitric oxide synthase. Br J Pharmacol 1995;116:3288-3292.
3. Hamman B, Bittl J, Jacobus W, Allen P, Spencer R, Tian R, Ingwall J: Inhibition of the creatine kinase reaction decreases the contractile reserve of isolated rat hearts. Am J Physiol 1995;269:H1030-H1036.
4. Omran H, Illien S, MacCarter D, St Cyr J, Luderitz B: D-ribose improves diastolic function and quality of life in congestive heart failure patients: A prospective feasibility study. Eur J Heart Fail 2003;5:615-619.
5. Pliml W, Von Arnim T, Stablein A, Hofmann H, Zimmer HG, Erdmann E: Effects of ribose on exercise-induced ischaemia in stable coronary artery disease. Lancet 1992;340:507-510.
6. Wallen WJ, Belanger MP, Wittnich C: Preischemic administration of ribose to delay the onset of irreversible ischemic injury and improve function: Studies in normal and hypertrophied hearts. Can J Physiol Pharmacol 2003;81:40-47.
7. Corno AF, Milano G, Samaja M, Tozzi P, Von Segesser LK: Chronic hypoxia: A model for cyanotic congenital heart defects. J Thorac Cardiovasc Surg 2002;124:105-112.
8. Wallis J, Lygate CA, Fischer A, ten Hove M, Schneider JE, Sebag-Montefiore L, Dawson D, Hulbert K, Zhang W, Zhang MH, Watkins H, Clarke K, Neubauer S: Supranormal myocardial creatine and phosphocreatine concentrations lead to cardiac hypertrophy and heart failure: Insights from creatine transporter-overexpressing transgenic mice. Circulation 2005;112:3131-3139.
9. Kammermeier H: Why do cells need phosphocreatine and a phosphocreatine shuttle. J Mol Cell Cardiol 1987;19:115-118.
10. Andrews R, Greenhaff P, Curtis S, Perry A, Cowley AJ: The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur Heart J 1998;19:617-622.
11. Gordon A, Hultman E, Kaijser L, Kristjansson S, Rolf C, Nyquist O, Sylven C: Creatine supplementation in chronic heart failure increases skeletal muscle creatine phosphate and muscle performance. Cardiovasc Res 1995;30:413-418.
12. Zhu S, Li M, Figueroa BE, Liu A, Stavrovskaya IG, Pasinelli P, Beal MF, Brown RH Jr, Kristal BS, Ferrante RJ, Friedlander RM: Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J Neurosci 2004;24:5909-5912.
13. 2+ handling and survival in mdx skeletal muscle cells. FEBS Lett 1998;439:357-362.
14. Op't Eijnde B, Van Leemputte M, Brouns F, Van Der Vusse GJ, Labarque V, Ramaekers M, Van Schuylenberg R, Verbessem P, Wijnen H, Hespel P, No effects of oral ribose supplementation on repeated maximal exercise and de novo atp resynthesis, J Appl Physiol, 2001, 91, 2275-2281.
15. Smolenski RT, Kalsi KK, Zych M, Kochan Z, Yacoub MH: Adenine/ribose supply increases adenosine production and protects atp pool in adenosine kinase-inhibited cardiac cells. J Mol Cell Cardiol 1998;30:673-683. (Pubitemid 28132744)
16. Zarzeczny R, Brault JJ, Abraham KA, Hancock CR, Terjung RL: Influence of ribose on adenine salvage after intense muscle contractions. J Appl Physiol 2001;91:1775-1781.
17. Hellsten Y, Skadhauge L, Bangsbo J: Effect of ribose supplementation on resynthesis of adenine nucleotides after intense intermittent training in humans. Am J Physiol Regul Integr Comp Physiol 2004;286:R182-188.
18. Brault JJ, Terjung RL: Purine salvage to adenine nucleotides in different skeletal muscle fiber types. J Appl Physiol 2001;91:231-238.
19. Zimmer HG: Significance of the 5-phosphoribosyl-1-pyrophosphate pool for cardiac purine and pyrimidine nucleotide synthesis: Studies with ribose, adenine, inosine, and orotic acid in rats. Cardiovasc Drugs Ther 1998;12:179-187.
20. + toxicity in an organotypic tissue culture system. Cell Transplant 2005;14:537-550.
21. Ducray A, Kipfer S, Huber AW, Andres RH, Seiler RW, Schlattner U, Wallimann T, Widmer HR: Creatine and neurotrophin-4/5 promote survival of nitric oxide synthase-expressing interneurons in striatal cultures. Neurosci Lett 2006;395:57-62.
22. Giannecchini M, Matteucci M, Pesi R, Sgarrella F, Tozzi MG, Camici M: Uptake and utilization of nucleosides for energy repletion. Int J Biochem Cell Biol 2005;37:797-808.
23. Laderoute KR, Amin K, Calaoagan JM, Knapp M, Le T, Orduna J, Foretz M, Viollet B: 5'-amp-activated protein kinase (ampk) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol Cell Biol 2006;26:5336-5347.
24. Takemura G, Fujiwara H: Morphological aspects of apoptosis in heart diseases. J Cell Mol Med 2006;10:56-75.
25. Milano G, Morel S, Bonny C, Samaja M, Von Segesser L, Nicod P, Vassalli G: A peptide inhibitor of c-jun nh2-terminal kinase (jnk) reduces myocardial ischemia/ reperfusion injury and infarct size in vivo. Am J Physiol 2007;292:H1828-H1835.
26. Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH: Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart. Circ Res 2000;86:692-699.
27. Gurusamy N, Das DK: Autophagy, redox signaling, and ventricular remodeling. Antioxid Redox Signal 2009;11:1975-1988.
28. Matsui Y, Takagi H, Qu X, Abdellatif M, Sakoda H, Asano T, Levine B, Sadoshima J: Distinct roles of autophagy in the heart during ischemia and reperfusion: Roles of amp-activated protein kinase and beclin 1 in mediating autophagy. Circ Res 2007;100:914-922.
29. Morrow VA, Foufelle F, Connell JM, Petrie JR, Gould GW, Salt IP: Direct activation of amp-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem 2003;278:31629-31639.
30. Levine YC, Li GK, Michel T: Agonist-modulated regulation of amp-activated protein kinase (ampk) in endothelial cells. Evidence for an ampk -> rac1 -> akt -> endothelial nitric-oxide synthase pathway. J Biol Chem 2007;282:20351-20364.
31. Nagata D, Mogi M, Walsh K: Amp-activated protein kinase (ampk) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 2003;278:31000-31006.
32. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K: Adiponectin stimulates angiogenesis by promoting cross-talk between amp-activated protein kinase and akt signaling in endothelial cells. J Biol Chem 2004;279:1304-1309. (Pubitemid 38082655)
33. Cai Y, Wang Q, Ling Z, Pipeleers D, McDermott P, Pende M, Heimberg H, Van de Casteele M: Akt activation protects pancreatic beta cells from ampk-mediated death through stimulation of mtor. Biochem Pharmacol 2008;75:1981-1993.
34. Soltys CL, Kovacic S, Dyck JR: Activation of cardiac amp-activated protein kinase by lkb1 expression or chemical hypoxia is blunted by increased akt activity. Am J Physiol Heart Circ Physiol 2006;290:H2472-H2479.
35. Hanada M, Feng J, Hemmings BA: Structure, regulation and function of pkb/ akt-a major therapeutic target. Biochim Biophys Acta 2004;1697:3-16.
36. Pachori AS, Smith A, McDonald P, Zhang L, Dzau VJ, Melo LG: Heme-oxygenase-1-induced protection against hypoxia/ reoxygenation is dependent on biliverdin reductase and its interaction with pi3k/ akt pathway. J Mol Cell Cardiol 2007;43:580-592.
37. Mukherjee S, Lekli I, Das M, Azzi A, Das DK: Cardioprotection with alpha-tocopheryl phosphate: Amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through akt activation. Biochim Biophys Acta 2008;1782:498-503.
38. Aikin R, Maysinger D, Rosenberg L: Cross-talk between phosphatidylinositol 3-kinase/akt and c-jun nh2-terminal kinase mediates survival of isolated human islets. Endocrinology 2004;145:4522-4531.